{
    "eid": "2-s2.0-85161312681",
    "title": "SABAs as Reliever Medications in Asthma Management: Evidence-Based Science",
    "cover-date": "2023-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "As-needed reliever",
        "Asthma management",
        "SABA",
        "Scientific evidence",
        "Short-acting \u03b22-agonists"
    ],
    "authors": [
        "Israel Amirav",
        "Gabriel Garcia",
        "Bao Khac Le",
        "Paulina Barria",
        "Gur Levy",
        "Bhumika Aggarwal",
        "Kyle Fahrbach",
        "Amber Martin",
        "Abhay Phansalkar",
        "Thitiwat Sriprasart"
    ],
    "citedby-count": 0,
    "ref-count": 64,
    "ref-list": [
        "Global strategy for asthma management and prevention",
        "BTS/SIGN British guideline on the management of asthma",
        "Focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group",
        "2021 Canadian Thoracic Society Guideline: a focused update on the management of very mild and mild asthma",
        "Japanese guidelines for adult asthma 2020",
        "Korean asthma guideline 2014: summary of major updates to the Korean asthma guideline 2014",
        "[Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1 highlights and controversies",
        "Guidelines for the management of asthma in adults: evidence and recommendations",
        "Asthma and COVID-19: in defense of evidence-based SABA",
        "Asthma rescue treatments, time to reboot",
        "The paradoxes of asthma management: time for a new approach?",
        "The changing asthma management landscape and need for appropriate SABA prescription",
        "Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007",
        "Consensus on mild asthma management: results of a modified Delphi study",
        "Patients' and physicians' perspectives on the burden and management of asthma: results from the APPaRENT 2 study",
        "Safety of SABA monotherapy in asthma management: a systematic review and meta-analysis",
        "The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity",
        "The most fundamental change in asthma management in 30 years?",
        "A review on the safety and efficacy of inhaled corticosteroids in the management of asthma",
        "New versus old: the impact of changing patterns of inhaled corticosteroid prescribing and dosing regimens in asthma management",
        "Low-dose inhaled corticosteroids and the prevention of death from asthma",
        "Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma",
        "A 10 year asthma programme in Finland: major change for the better",
        "Exercise-induced bronchoconstriction: prevalence, pathophysiology, patient impact, diagnosis and management",
        "An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction",
        "Primary care management of asthma exacerbations or attacks: impact of the COVID-19 pandemic",
        "Treatment patterns among non-active users of maintenance asthma medication in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink",
        "Asthma control and management in 8,000 European patients: the Recognise Asthma and Link To Symptoms and Experience (REALISE) survey",
        "Why asthma still kills: The national review of asthma deaths (NRAD); confidential enquiry report 2014",
        "Urban adults' perceptions of factors influencing asthma control",
        "Asthma medication adherence among urban teens: a qualitative analysis of barriers, facilitators and experiences with school-based care",
        "Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study",
        "SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting \u03b22-agonist use in asthma",
        "Overuse of short-acting \u03b22-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme",
        "Asthma-related health outcomes associated with short-acting \u03b22-agonist inhaler use: an observational UK study as part of the SABINA global program",
        "Short-acting \u03b22-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III",
        "Over-prescription of short-acting \u03b22-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study",
        "Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies",
        "Usage patterns of short-acting \u03b22-agonists and inhaled corticosteroids in asthma: a targeted literature review",
        "Short-acting \u03b2-agonist use and its ability to predict future asthma-related outcomes",
        "Cause or consequence?",
        "Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial",
        "Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma",
        "Long-term use of short-acting \u03b22-agonists in patients with adult-onset asthma",
        "The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting \u03b22-agonists in the United Kingdom: a cross-sectional analysis",
        "Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years",
        "Asthma control assessment tools",
        "Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the Goal study",
        "Asthma control over 3 years in a real-life study",
        "Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey",
        "Insights from the AUSTRI study on reliever use before and after asthma exacerbations",
        "Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations",
        "Self-management education and regular practitioner review for adults with asthma",
        "Benefits of an asthma education program provided at primary care sites on asthma outcomes",
        "Asthma education: an essential component in asthma management",
        "Written action plans for asthma: an evidence-based review of the key components",
        "Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations",
        "The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta2-agonists in people with asthma: a protocol for a systematic review",
        "Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London",
        "Validation of the 'test of the adherence to inhalers' (TAI) for asthma and COPD patients",
        "Essential role of pharmacists in asthma care and management",
        "Understanding patient perspectives on medication adherence in asthma: a targeted review of qualitative studies"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bethesda",
            "@id": "60112053",
            "affilname": "Evidera, USA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60112053",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Mumbai",
            "@id": "60111469",
            "affilname": "GlaxoSmithKline Pharmaceuticals Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111469",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Santiago",
            "@id": "60105951",
            "affilname": "Fuerza A\u00e9rea De Chile Hospital Cl\u00ednico Gral. Dr. Ra\u00fal Yazigi J.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105951",
            "affiliation-country": "Chile"
        },
        {
            "affiliation-city": "La Plata",
            "@id": "60092108",
            "affilname": "Hospital Prof. Rodolfo Rossi, La Plata",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60092108",
            "affiliation-country": "Argentina"
        },
        {
            "affiliation-city": "Ho Chi Minh City",
            "@id": "60071418",
            "affilname": "University of Medicine and Pharmacy at HCMC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071418",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Brentford",
            "@id": "60020649",
            "affilname": "GlaxoSmithKline plc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020649",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Tel Aviv-Yafo",
            "@id": "60008870",
            "affilname": "Tel Aviv Sourasky Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008870",
            "affiliation-country": "Israel"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "122683902",
            "affilname": "Emerging Markets",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122683902",
            "affiliation-country": "Singapore"
        }
    ],
    "funding": [
        "Abbott",
        "AstraZeneca",
        "Boehringer Ingelheim",
        "GSK",
        "Novartis",
        "Pfizer",
        "Sanofi",
        "Sanofi-Aventis",
        "Sourabh Fulmali and Ebru Yildiz",
        "GSK"
    ]
}